| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/07853890903376280 |
| P698 | PubMed publication ID | 20092399 |
| P50 | author | Andrej Tarkowski | Q100328748 |
| P2093 | author name string | Maria Bokarewa | |
| Ingiäld Hafström | |||
| Björn Svensson | |||
| Kristina Forslind | |||
| Kristina Albertsson | |||
| P2860 | cites work | Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction | Q24792135 |
| Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis | Q24804174 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Validating survivin as a cancer therapeutic target | Q28201382 | ||
| Targeting survivin in cancer therapy: fulfilled promises and open questions | Q28291799 | ||
| The costs of rheumatoid arthritis: an international long-term view | Q33915358 | ||
| Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis | Q34634283 | ||
| Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage | Q35552357 | ||
| Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study | Q35554180 | ||
| Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). | Q35554508 | ||
| Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). | Q35554533 | ||
| Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis? | Q35554765 | ||
| Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study | Q35636621 | ||
| Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. | Q36600496 | ||
| Survivin: a promising tumor biomarker | Q36726840 | ||
| The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register | Q36732099 | ||
| Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients | Q42619505 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 45-54 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Annals of Medicine | Q4767853 |
| P1476 | title | Increased expression of proto-oncogene survivin predicts Joint destruction and persistent disease activity in early rheumatoid arthritis | |
| P478 | volume | 42 |
| Q90354326 | A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis - results of clinical relevance |
| Q34452194 | Activation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis |
| Q35193842 | Novel insights into the regulatory architecture of CD4+ T cells in rheumatoid arthritis |
| Q36153255 | Recognizing rheumatoid arthritis: oncoprotein survivin opens new possibilities: a population-based case-control study |
| Q33673624 | Rheumatoid Arthritis Fibroblast-like Synoviocyte Suppression Mediated by PTEN Involves Survivin Gene Silencing |
| Q35792901 | Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial |
| Q37689716 | Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of survivin in early rheumatoid arthritis: a prospective cohort study |
| Q36433351 | Suppressed diversity of survivin splicing in active rheumatoid arthritis. |
| Q58803456 | Survivin Measurement improves Clinical Prediction of Transition From Arthralgia to RA-Biomarkers to Improve Clinical Sensitivity of Transition From Arthralgia to RA |
| Q37689919 | Survivin but not Fms-like tyrosine kinase 3 ligand is up-regulated before the onset of rheumatoid arthritis: a pilot study |
| Q43164202 | Survivin co-ordinates formation of follicular T-cells acting in synergy with Bcl-6. |
| Q33951067 | The oncofetal gene survivin is re-expressed in osteoarthritis and is required for chondrocyte proliferation in vitro |
| Q35635793 | The proto-oncogene survivin splice variant 2B is induced by PDGF and leads to cell proliferation in rheumatoid arthritis fibroblast-like synoviocytes. |
Search more.